IL-15 Antikörper (AA 70-162) (APC)
Kurzübersicht für IL-15 Antikörper (AA 70-162) (APC) (ABIN8001910)
Target
Alle IL-15 (IL15) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 70-162
-
Verwendungszweck
- Anti-IL15 Antibody APC Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human IL15 recombinant protein (Position: D70-S162).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- IL-15 (IL15) (Interleukin 15 (IL15))
-
Andere Bezeichnung
- IL15
-
Hintergrund
-
Background: Interleukin (IL)-15 is a cytokine with the ability to stimulate the proliferation activity of Th1 and/or Th2 lymphocytes. This gene is mapped to human chromosome 4q31 by fluorescence in situ hybridization. IL-15 is a novel cytokine whose effects on T-cell activation and proliferation are similar to those of interleukin-2 (IL-2), presumably because IL-15 utilizes the beta and gamma chains of the IL-2 receptor. IL-15 can play a role in the initiation and outcome of acute and chronic rejection. Anti-IL-15 therapy in combination with classic immunosuppression therapy might be beneficial in the prevention of acute, and especially chronic, allograft rejection.
Gene Full Name: interleukin 15
-
Gen-ID
- 3600
-
UniProt
- P40933
-
Pathways
- JAK-STAT Signalweg, Glycosaminoglycan Metabolic Process
Target
-